ACTIVITY IN THE THIRD QUARTER OF 2012
ACTIVITY IN THE THIRD QUARTER OF 2012
(Unaudited data)
CUMULATIVE ACTIVITY AS OF THE END OF SEPTEMBER 2012
thousands of euros
2011
2012
Variation at current exchange rates
Variation at constant exchange rates
France
210,153
233,426
+11.1%
+11.1%
International :
163,491
165,959
+1.5%
+0.0%
Incl. Europe excluding France
130,917
126,041
-3.7%
-3.8%
Incl. North America
26,756
31,282
+16.9%
+7.5%
Incl. Other countries
5,818
8,636
+48.4%
+50.3%
Group Total
373,644
399,385
+6.9%
+6.2%
thousands of euros
2011
2012
Variation at current exchange rates
Variation at constant exchange rates
Non-proprietary Homeopathic Medicines
195,031
213,592
+9.5%
+9.1%
OTC Specialties
178,561
185,394
+3.8%
+2.9%
Other
0,052
0,399
Group Total
373,644
399,385
+6.9%
+6.2%
DEVELOPMENT OF BUSINESS IN THE THIRD QUARTER (VARIATION AT CURRENT RATE)
thousands of euros
1st Quarter
2nd Quarter
3rd Quarter
2011
2012
Var.
2011
2012
Var.
2011
2012
Var.
France
70,466
74,188
+5.3%
59,744
71,210
+19.2%
79,943
88,028
+10.1%
International :
58,478
54,904
-6.1%
37,128
41,216
+11.0%
67,885
69,839
+2.9%
Incl. Europe excluding France
47,024
41,807
-11.1%
28,880
28,889
+0.0%
55,013
55,345
+0.6%
Incl. North America
9,566
10,285
+7.5%
6,113
9,861
+61.3%
11,077
11,136
+0.5%
Incl. Other countries
1,888
2,812
+48.9%
2,135
2,466
+15.5%
1,795
3,358
+87.1%
Group Total
128,944
129,092
+0.1%
96,872
112,426
+16.1%
147,828
157,867
+6.8%
thousands of euros
1st Quarter
2nd Quarter
3rd Quarter
2011
2012
Var.
2011
2012
Var.
2011
2012
Var.
Non-proprietary Homeopathic Medicines
69,371
73,427
+5.8%
62,414
70,206
+12.5%
63,246
69,959
+10.6%
OTC Specialties
59,417
55,576
-6.5%
34,499
42,007
+21.8%
84,645
87,811
+3.7%
Other
0,156
0,089
-0,041
0,213
-0,063
0,097
Group Total
128,944
129,092
+0.1%
96,872
112,426
+16.1%
147,828
157,867
+6.8%
THIRD QUARTER HIGHLIGHTS
Sales revenue in the third quarter grew by 6.8% at actual exchange rates (5.9% at constant exchange rates):
In France, sales of non-proprietary medicines increased by 15.3% due to the price increases applied to some of them.
Internationally, the trends varied between countries. Sales increased by 2.9% notably due to favorable currency impacts.
As of September 30, 2012, the group's net cash amounted to €98.7 million (versus €76.2 million as of June 30, 2012). This improvement in the group's net cash position was related to the growth in sales as well as decreases in investment expenditures.
In the United States, the settlement agreement signed on March 6, 2012 aiming at putting an end to all class action litigation in process (with the exception of the lawsuit related to Children's Coldcalm®) has obtained the prior approval of the San Diego court. A hearing on the agreement final approval took place on October 1, 2012. Boiron USA is awaiting the court's decision.
OUTLOOK
Despite uncertainties related to the economic environment, Boiron confirms its targets of increased sales revenue and income in 2012.
CENTRAL WORKS COUNCIL MEETING
On October 25, 2012, the central works council of BOIRON SA met within the framework of an information and consultation procedure. Senior management reminds the council of the provisions of the European Directive on the status of homeopathic medicines in France and the consequences that could arise in the medium term for the company's strategy and organization. Senior management indicated that it currently foresees no immediate social consequences.
Next update: January 24th 2013, after the close of the stock market, publication of 2012 sales.
Financial information manager: Philippe MONTANT
Contact for financial information: Véronique BOUSCAYROL
Investor relations: +33 (0) 4.78.45.63.43 - e-mail: finances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg : BOI FP - Reuters : BOIR.PA
The group's financial information is online at : www.boiron.com
Information réglementée
Communiqués au titre de l'obligation d'information permanente :
- Communiqué sur comptes, résultats, chiffres d'affaires
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-29791-cp-boiron-251012.pdf
Communiqués au titre de l'obligation d'information permanente :
- Communiqué sur comptes, résultats, chiffres d'affaires
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-29791-cp-boiron-251012.pdf
<!-- 90 -->
© Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free